Study Of ISB 1342, A CD38/​CD3 Bispecific Antibody, In Subjects With Previously Treated Multiple Myeloma

Overview

About this study

The purpose of this study is to determine the safety profile, maximum tolerable dose (MTD) and cohort expansion of single-agent GBR 1342 in subjects with multiple myeloma who have received prior therapies.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria: -Adults with progressive or relapsed multiple myeloma (by IMWG) refractory to proteasome inhibitors (PIs), immunomodulators (IMiDs) and daratumumab. -Measurable disease, defined as any quantifiable monoclonal protein value -ECOG performance-status score of 2 or less -Life expectancy of at least 3 months -Recovered from any previous surgery and no history of major surgery within the last 28 days prior to start of study drug Exclusion Criteria: -Any condition that, in the opinion of the Investigator, would interfere with evaluation of the study drug or interpretation of subject safety or study results. -Active infectious disease considered by the Investigator to be incompatible with the protocol. -Evidence of clinically significant cardiovascular and respiratory conditions -Anti-myeloma treatment within 2 weeks -Use of any investigational drug within the past 4 weeks

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Prashant Kapoor, M.D.

Closed for enrollment

Contact information:

Cancer Center Clinical Trials Referral Office

(855) 776-0015

More information

Publications

Publications are currently not available
.
CLS-20507130

Mayo Clinic Footer